Products

ConcertAI Clinical Trial Solutions (PrecisionTrials™)
ConcertAI
Drug Discovery & Research
ConcertAI's PrecisionTrials™ is an AI SaaS solution that uses real-world data and generative AI to optimize clinical trial design, site selection, and patient recruitment, providing actionable insights for clinical teams.

See all 1 product →

About ConcertAI

ConcertAI is a real-world healthcare intelligence company that leverages artificial intelligence (AI) and comprehensive clinical and genomic datasets to advance research, treatment, and care, particularly in oncology and other complex diseases. For physicians, ConcertAI’s solutions aim to provide faster, more contextualized intelligence to support clinical trial matching and treatment decisions directly within existing clinical workflows. This includes the ability to compare individual patients against real-world cohorts from a robust dataset of over 13 million patient records to evaluate standard treatments and outcomes, and to identify and address critical care gaps.

The company’s offerings, such as the enhanced CancerLinQ® Suite, utilize clinically intelligent AI to process large volumes of structured and unstructured data weekly. This allows for the identification of trial-eligible patients more rapidly and surfaces real-world cohort comparisons. ConcertAI’s mission is to accelerate insights, clinical trials, and commercial outcomes for life sciences and healthcare clients, ultimately improving patient outcomes through leading real-world data, AI technologies, and scientific expertise.

What Physicians Need to Know

Specialization: Oncology & Complex Diseases
ConcertAI focuses on applying AI to oncology and other complex diseases, offering solutions across the entire lifecycle from research and clinical trials to treatment and delivery.
Core Technology: Cara AI Engine & Agentic AI
Their proprietary AI engine, Cara, is trained on millions of human-curated clinical records and petabytes of data. ConcertAI leverages generative and agentic AI, which involves a network of specialized AI 'agents' (including large and small language models) to automate complex tasks and provide evidence-based insights.
Data Foundation: Real-World Evidence (RWE)
ConcertAI boasts a comprehensive real-world evidence (RWE) platform, integrating longitudinal clinical and genomic data from a vast network, including the CancerLinQ network with over 9 million patient records from nearly 1000 oncology sites across all 50 states. This data includes physician notes, radiology reports, lab results, and genomic/NGS laboratory reports.
Clinical Trials Acceleration
They offer 'Accelerated Clinical Trials (ACT)' solutions that use AI-driven workflows to streamline protocol design, automate site selection, and enhance patient matching, aiming to significantly reduce trial timelines and costs.
Enterprise Imaging (TeraRecon)
Through TeraRecon, a ConcertAI company, they provide advanced visualization and AI-driven automations for medical imaging across specialties like radiology, oncology, cardiology, and neurology, integrating imaging workflows with broader patient care contexts.
Physician Tip

ConcertAI's tools aim to provide physicians with practical intelligence drawn directly from everyday care, offering clinical decision support and trial-matching capabilities. Their AI-powered systems can help interpret complex clinical references, extract key variables from various inputs (notes, reports, labs), and surface patients who might qualify for newer therapies based on updated criteria. This can lead to faster patient screening for clinical trials (over 3x faster than traditional methods) and help close the gap between routine clinical care and research, ensuring patients have access to the most current treatment options. The focus is on providing trustworthy, evidence-based insights by ensuring AI agents operate on vetted, domain-specific information.

ConcertAI emphasizes a connected ecosystem, collaborating with leading laboratory partners (e.g., Caris, Guardant, Foundation Medicine, NeoGenomics) to integrate deep genomic and molecular insights. They also work with technology partners like NVIDIA and AWS to power scalable and secure intelligence infrastructure. Their solutions are designed to integrate with existing clinical workflows and are agnostic to EHR vendors and genomic/molecular labs.

Products by ConcertAI

1 product in the directory

ConcertAI Clinical Trial Solutions (PrecisionTrials™)
ConcertAI
Drug Discovery & Research
ConcertAI's PrecisionTrials™ is an AI SaaS solution that uses real-world data and generative AI to optimize clinical trial design, site selection, and patient recruitment, providing actionable insights for clinical teams.

What the Web Says

ConcertAI is a company focused on accelerating biomedical innovations through AI SaaS and real-world data solutions in oncology. They offer products like RWD360 and Patient360 for detailed patient journey insights and abstracted datasets, and their newer AI platforms like Accelerated Clinical Trials (ACT) and CARAai aim to significantly reduce trial timelines and costs. While some employees praise the opportunity to work on interesting problems with smart people, employer reviews frequently highlight significant issues with management, work-life balance, and job security.

Overall: Mixed

Strengths

  • Opportunity to work on interesting problems in healthcare and life science research.
  • Smart and capable colleagues.
  • Good for new graduates seeking initial experience in the field.
  • Offers good benefits.
  • Products like RWD360 and Patient360 provide comprehensive real-world data and insights.
  • AI-powered platforms (ACT, CARAai) show promise in accelerating clinical trials and improving efficiency.

Limitations

  • Poor management, including harsh communication, blame-shifting, and taking credit for others' ideas.
  • Lack of work-life balance, with expectations of long hours and 24/7 collaboration.
  • Low job security and advancement opportunities, with reports of layoffs and outsourcing.
  • Toxic company culture where one person's opinion can dominate.
  • Strained development resources leading to project delays and constant priority battles.
  • Lackluster training programs with high expectations for job knowledge.

Based on reviews from: Indeed.com, Glassdoor, Great Place To Work®, Elion Health, Reddit, AI-Tech Park, TechTarget, PR Newswire, RFP.wiki, MobiHealthNews

Last updated: 2026-10-26

Videos

News, demos, and interviews about ConcertAI.

Loading videos...

Videos load interactively. If none appear, search YouTube for ConcertAI →

View all on YouTube

Press & Coverage

TechTarget
ConcertAI unveils agentic AI tool to cut trial timelines, costs
ConcertAI launched its Accelerated Clinical Trials (ACT) platform, an agentic AI tool designed to reduce clinical trial timelines by 10-20 months and study design time by up to 50%. The platform utilizes ConcertAI's CARAai framework, integrating real-world and proprietary data with predictive analytics to automate core trial activities.
2026-02
Business Wire
ConcertAI Expands CancerLinQ Suite with AI-Driven Trial Matching and Contextualized Patient Insights to Support Oncologists at the Point of Care
ConcertAI announced enhancements to its CancerLinQ Suite, leveraging clinically intelligent AI to provide oncologists and clinical care teams with faster, more contextualized intelligence for clinical trial matching and treatment decisions within their existing workflows. These new capabilities were unveiled at the 2026 ASCO Annual Meeting.
2026-05
ConcertAI
ConcertAI Introduces Cadence Suite, Delivering Industry Leading Visibility and Predictive Insights into the Patient's Journey for Commercial Teams
ConcertAI introduced Cadence Suite, an AI-native suite of applications for pharmaceutical commercial and field teams. It aims to identify and resolve patient access barriers before they disrupt therapy, providing near real-time visibility across the brand and patient journey.
2026-04
ConcertAI
ConcertAI named to TIME's World's Top HealthTech Companies of 2026
ConcertAI was recognized by TIME as one of the World's Top HealthTech Companies of 2026.
2026-09
PR Newswire
ConcertAI's TeraRecon Launches Three New Care Suites, Life Sciences Platform, and Strategic Partnerships at #ECR24
ConcertAI's TeraRecon, a KLAS-ranked advanced visualization and AI Clinical SaaS solution, announced the launch of three new Care Suites, a Life Sciences Platform, and strategic partnerships at ECR24, expanding its offerings for European healthcare providers.
2024-02
PR Newswire
ConcertAI introduces predictive and generative AI solutions powered by multi-modal real-world data, key partnerships, CARA AI, and more at the 2024 ASCO Annual Meeting
ConcertAI showcased its predictive and generative AI solutions, powered by multi-modal real-world data, key partnerships, and CARA AI, at the 2024 ASCO Annual Meeting.
2024-05
PR Newswire
ConcertAI: 2024 ASCO Annual Meeting study demonstrates that AI models for predicting patient availability for clinical trials showed a 2 - 4x improvement over traditional approaches
A study presented at the 2024 ASCO Annual Meeting by ConcertAI demonstrated that AI models significantly improved the prediction of patient availability for clinical trials, showing a 2-4x improvement over traditional methods.
2024-06
MobiHealthNews
ConcertAI scores $150M, valuation skyrockets to nearly $2B
ConcertAI secured $150 million in Series C funding from Sixth Street, boosting the company's valuation to $1.9 billion. This funding will support its real-world data and AI offerings for life sciences and healthcare.
2022-03

Frequently Asked Questions

ConcertAI provides a range of AI-driven solutions primarily focused on oncology and real-world evidence. Their products include AI-powered applications for precision oncology, clinical trial optimization, and research, aiming to improve patient outcomes and operational efficiency.
ConcertAI prioritizes data privacy and security, adhering to strict compliance standards such as HIPAA and GDPR. They employ robust de-identification techniques and secure data environments to protect patient information while leveraging it for research and clinical insights.
ConcertAI's pricing models are generally tailored to the specific solutions and scale of deployment within a healthcare organization. They offer customizable options to accommodate different organizational sizes and needs, which can be discussed directly with their sales team.
ConcertAI provides comprehensive implementation support, including training for clinical and administrative staff, and ongoing technical assistance. Their goal is to ensure seamless integration and effective utilization of their AI platforms within existing healthcare workflows.
ConcertAI collaborates with leading life science companies, academic institutions, and healthcare providers to advance oncology research and real-world evidence. These partnerships enable them to integrate diverse datasets, develop cutting-edge AI solutions, and bring innovative therapies to patients faster.
ConcertAI is a well-established company with significant investment and a clear long-term vision for transforming healthcare through AI and real-world evidence. Their financial stability and commitment to innovation ensure sustained support, continuous product evolution, and reliable partnership for their clients.
ConcertAI's AI solutions are designed for interoperability and can integrate with various existing electronic health record (EHR) systems and other clinical IT infrastructure. They work to ensure seamless data flow and minimal disruption to current workflows.

Related Companies

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company that focuses on the discovery, development, and commercialization of prescription medicines. The company’s portfolio addresses major diseases in areas such as oncology, rare diseases, and biopharmaceuticals, which include cardiovascular, renal & metabolism, and respiratory & immunology. AstraZeneca operates globally, with a significant commercial presence in […]

Google DeepMind is a British-American artificial intelligence (AI) research laboratory and a subsidiary of Alphabet Inc.. Formed in April 2023 through the merger of DeepMind and Google AI’s Google Brain division, the company focuses on advancing artificial general intelligence (AGI) and developing AI systems for widespread public benefit and scientific discovery. Their work involves an […]

MyTrials.ai is a healthcare AI company dedicated to revolutionizing access to clinical trials for patients and streamlining recruitment for researchers. The platform leverages artificial intelligence and clinical expertise to match patients with suitable clinical trials based on their health profiles, preferences, and values. This approach aims to simplify complex medical information, making it easier for […]

2 Minute Medicine is a peer-reviewed and physician-led medical publishing and original news syndication company founded in 2012 by Marc D. Succi, a physician at Massachusetts General Hospital/Harvard Medical School. The company focuses on curating, writing, and editing high-impact medical news and research summaries, with all content created and peer-reviewed by practicing physicians and health […]

Scite (scite.ai) is an AI-powered research platform designed to help physicians and researchers discover and critically evaluate scientific literature. Unlike traditional citation tools that merely count citations, Scite utilizes “Smart Citations” to provide deeper insights into how publications cite each other. It classifies citation statements from over 300 million scholarly articles, preprints, books, patents, and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.